Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Am J Perinatol ; 39(4): 387-393, 2022 03.
Artigo em Inglês | MEDLINE | ID: mdl-32892326

RESUMO

OBJECTIVE: Neonatal opioid withdrawal syndrome (NOWS) describes infants' withdrawal signs and symptoms after birth due to an interruption of prenatal opioid exposure. Many infants with NOWS are also exposed to nonopioids, however. This study was to determine hospital outcomes of infants exposed to opioids alone or coexposed with nonopioid substances (polysubstance). STUDY DESIGN: We reviewed infants of ≥34 weeks of gestation with prenatal opioid exposure from April 2015 to May 2018. We compared the median lengths of stay (LOS) and treatment (LOT) and the percentages of infants requiring pharmacologic and adjunctive treatment in infants exposed to opioids alone or polysubstance. We used Wilcoxon's test for continuous outcomes or Chi-squared test for categorical outcomes to determine statistical significance. We used multivariable regression model to calculate each drug category's estimates of adjusted mean ratios for LOS and LOT plus estimates of adjusted odds ratios for pharmacologic/adjunctive treatments. RESULTS: Of the 175 infants, 33 (19%) infants had opioid exposure alone. Opioid exposure included short- and/or long-acting opioids. A total of 142 (81%) had polysubstance exposure with 47% of mothers using nicotine products. We saw similar hospital outcomes between infants exposed to opioids alone or polysubstance; however, a higher percentage of infants with both short- and long-acting opioid exposure required pharmacologic treatment compared with either opioid alone. Focusing on individual drug categories, we detected differential hospital outcomes in which short-acting opioids decreased LOT, whereas long-acting opioids increased LOS, LOT, and need for pharmacologic and adjunctive treatment. Coexposure of opioids with stimulants decreased LOT and reduced need for adjunctive treatment. Coexposures with antidepressants increased LOT, while with antiepilepetics increased LOS. CONCLUSION: Because infants with NOWS often have coexposures to other nonopioid substances, appreciating the associated risks of individual or combination of drugs in modulating hospital outcomes may help counsel families on their infants' expected hospital course. KEY POINTS: · Hospital outcomes were similar between infants exposed to opioids alone or polysubstance including opioids.. · Infants with short- and long-acting opioids required pharmacologic treatment more often than either opioid alone.. · Differential hospital outcomes exist for various co-exposures of opioids with nonopioids..


Assuntos
Analgésicos não Narcóticos , Síndrome de Abstinência Neonatal , Transtornos Relacionados ao Uso de Opioides , Analgésicos não Narcóticos/uso terapêutico , Analgésicos Opioides/efeitos adversos , Feminino , Humanos , Lactente , Recém-Nascido , Tempo de Internação , Mães , Síndrome de Abstinência Neonatal/diagnóstico , Síndrome de Abstinência Neonatal/tratamento farmacológico , Síndrome de Abstinência Neonatal/epidemiologia , Transtornos Relacionados ao Uso de Opioides/tratamento farmacológico , Transtornos Relacionados ao Uso de Opioides/epidemiologia , Gravidez , Centros de Atenção Terciária
2.
Dev Psychopathol ; 31(3): 833-846, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-31057128

RESUMO

We investigated whether neurobehavioral markers of risk for emotion dysregulation were evident among newborns, as well as whether the identified markers were associated with prenatal exposure to maternal emotion dysregulation. Pregnant women (N = 162) reported on their emotion dysregulation prior to a laboratory assessment. The women were then invited to the laboratory to assess baseline respiratory sinus arrhythmia (RSA) and RSA in response to an infant cry. Newborns were assessed after birth via the NICU Network Neurobehavioral Scale. We identified two newborn neurobehavioral factors-arousal and attention-via exploratory factor analysis. Low arousal was characterized by less irritability, excitability, and motor agitation, while low attention was related to a lower threshold for auditory and visual stimulation, less sustained attention, and poorer visual tracking abilities. Pregnant women who reported higher levels of emotion dysregulation had newborns with low arousal levels and less attention. Larger decreases in maternal RSA in response to cry were also related to lower newborn arousal. We provide the first evidence that a woman's emotion dysregulation while pregnant is associated with risks for dysregulation in her newborn. Implications for intergenerational transmission of emotion dysregulation are discussed.


Assuntos
Nível de Alerta/fisiologia , Atenção/fisiologia , Emoções/fisiologia , Arritmia Sinusal Respiratória/fisiologia , Feminino , Humanos , Recém-Nascido , Masculino , Transtornos Mentais/fisiopatologia , Transtornos Mentais/psicologia , Gravidez , Complicações na Gravidez/psicologia
3.
Am J Emerg Med ; 37(6): 1153-1159, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30952605

RESUMO

Infant patients are a unique challenge to emergency department (ED) physicians as the spectrum of normal infant signs, symptoms and behaviors are often difficult to differentiate from abnormal and potentially life-threatening conditions. In this article, we address some common chief complaints of neonates and young infants presenting to the ED, and contrast reassuring neonatal and young infant signs and symptoms against those that need further workup and intervention.


Assuntos
Serviço Hospitalar de Emergência , Doenças do Recém-Nascido/diagnóstico , Oftalmopatias/diagnóstico , Gastroenteropatias/diagnóstico , Humanos , Lactente , Comportamento do Lactente , Recém-Nascido , Doenças Respiratórias/diagnóstico , Dermatopatias/diagnóstico
4.
Pediatrics ; 131(5): e1538-44, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23569092

RESUMO

BACKGROUND: Early readmissions of apparently healthy newborns after discharge from well baby nurseries (WBN) may reflect an inadequate assessment of the newborn's readiness for discharge. OBJECTIVE: To determine the frequency, causes, costs, and variations in rates of early rehospitalization of newborns discharged from 21 WBNs in 1 health care system. METHODS: We queried the Enterprise Data Warehouse of Intermountain Healthcare (IH), a large Utah health care system, to identify newborns with gestational ages of 34 to 42 weeks discharged from an IH WBN between 2000 and 2010. We identified all newborns admitted to an IH hospital within 28 days of discharge and recorded their birth hospital, age, reason(s) for admission, length of stay, and inpatient costs. RESULTS: During the study period, 296 114 infants were discharged from IH hospital WBNs. Of these, 5308 (17.9/1000) were readmitted within 28 days of discharge. Of the 5308 infants who were readmitted, 41% had feeding problems, 35% had jaundice, and 33% had respiratory distress. The majority of newborns with feeding problems and jaundice were admitted in their first 2 weeks of life. Late preterm and early term newborns had higher rates of readmission than term infants. There were significant variations in readmission rates of newborns born at the 21 hospitals in the IH system. CONCLUSIONS: Potentially preventable conditions, including feeding problems and jaundice, account for most early readmissions of newborns. Late preterm and early term newborns have higher rates of readmission and should be assessed for other factors associated with early readmission.


Assuntos
Atenção à Saúde , Bem-Estar do Lactente , Tempo de Internação , Readmissão do Paciente/estatística & dados numéricos , Estudos de Coortes , Intervalos de Confiança , Bases de Dados Factuais , Feminino , Idade Gestacional , Humanos , Incidência , Recém-Nascido , Masculino , Avaliação das Necessidades , Razão de Chances , Alta do Paciente/estatística & dados numéricos , Cuidado Pós-Natal , Estudos Retrospectivos , Medição de Risco , Fatores de Tempo , Utah
5.
Am J Perinatol ; 30(3): 241-4, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22879357

RESUMO

OBJECTIVES: Determine the prevalence of prenatal opioid and other drug positivity among women delivering infants in Utah and compare the findings with national data. STUDY DESIGN: Umbilical cord tissue samples and nonidentifiable demographic data were collected anonymously in 13 labor and delivery units throughout Utah. Samples were analyzed for opioids, amphetamines, cannabinoids, cocaine, phencyclidine, barbiturates, benzodiazepines, propoxyphene, and alcohol biomarkers. RESULTS: Fifty-eight (6.8%) of 850 umbilical cord samples were positive for one or more substances. Opioids were the most frequently detected drugs (4.7%). Fewer samples were positive for alcohol (0.4%), methamphetamine (0.1%), cocaine (0.1%), and marijuana (0.4%). CONCLUSION: Opioids were the most frequently detected drugs at delivery. Although some of the samples positive for opioids might have been a result of intrapartum exposure, a significant number were positive for opioids that are not given during labor. This parallels the increasing nonmedical use of prescription pain medications in the general population and has important implications for neonates because of the potential for significant morbidity secondary to neonatal abstinence syndrome.


Assuntos
Transtornos Relacionados ao Uso de Opioides/epidemiologia , Adulto , Consumo de Bebidas Alcoólicas/epidemiologia , Transtornos Relacionados ao Uso de Anfetaminas/epidemiologia , Transtornos Relacionados ao Uso de Cocaína/epidemiologia , Feminino , Sangue Fetal/química , Humanos , Abuso de Maconha/epidemiologia , Estado Civil , Troca Materno-Fetal , Medicaid , Pessoas sem Cobertura de Seguro de Saúde , Gravidez , Prevalência , Fatores de Risco , Fumar/epidemiologia , Estados Unidos , Utah/epidemiologia , Adulto Jovem
6.
Pediatrics ; 122(3): e703-9, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18762506

RESUMO

BACKGROUND: Investigators from several states have reported that children entering foster care are at risk for medical and mental health conditions. Additional information based on data from a larger statewide population of children in foster care would assist in the development of appropriate strategies of care for these children. OBJECTIVES: The purpose of this work was to describe the prevalence of medical and mental health conditions, the number of referrals for specialty care, the use of medications and to compare the prevalence of these conditions across age groups of children entering foster care in Utah. METHODS: We conducted an analysis of a statewide database containing abstracted medical and mental health information from the initial medical and mental health assessments of all children entering foster care between January 1, 2001, and December 16, 2004. RESULTS: Of the 6177 children who entered foster care during the study period, 83% were white and 24% were Hispanic. One or more acute or chronic medical conditions were present in 54%, and 44% had >/=1 mental health condition. The most prevalent medical conditions in all of the children were overweight or obesity (35%), 30% had a referral for specialty care. The most prevalent mental health conditions were oppositional defiant disorder or conduct disorder (18%), reactive attachment and adjustment disorders (17%), and mood disorders (15%). The frequency of psychotropic medication use increased with age. Of the 2747 children of all ages with a diagnosed mental health condition, 35% were receiving psychotropic medications. CONCLUSIONS: This study of a statewide cohort of children entering foster care supports and strengthens previous evidence that children in foster care are more likely to have more health care needs compared with the general pediatric population. Focused strategies are needed that address prevalent conditions, the need for continuity of care, ongoing mental health services, and medication management.


Assuntos
Consumo de Bebidas Alcoólicas/epidemiologia , Cuidados no Lar de Adoção , Transtornos Mentais/epidemiologia , Saúde Mental/estatística & dados numéricos , Obesidade/epidemiologia , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Adolescente , Consumo de Bebidas Alcoólicas/efeitos adversos , Criança , Pré-Escolar , Seguimentos , Humanos , Lactente , Recém-Nascido , Masculino , Transtornos Mentais/complicações , Obesidade/complicações , Prevalência , Prognóstico , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Transtornos Relacionados ao Uso de Substâncias/complicações , Utah/epidemiologia
8.
Arch Pediatr Adolesc Med ; 161(5): 457-61, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17485621

RESUMO

OBJECTIVES: To describe bottled, filtered, and tap water consumption and fluoride use among pediatric patients; to analyze differences between ethnic and socioeconomic groups; and to describe the frequency of physician-parent discussions regarding water consumption. DESIGN: Convenience sample survey. SETTING: An urban public health clinic. PARTICIPANTS: Parents attending a public health clinic. OUTCOME MEASURES: The primary outcome measure was the prevalence of tap, filtered, and bottled water use. The secondary outcome measures were supplemental fluoride use and the percentage of patients reporting discussions of water consumption with their physician. RESULTS: A total of 216 parents (80.5% Latino and 19.5% non-Latino) completed the survey. Of the parents, 30.1% never drank tap water and 41.2% never gave it to their children. Latino parents were less likely than non-Latino parents to drink tap water (odds ratio, 0.26; 95% confidence interval, 0.10-0.67) and less likely to give tap water to their children (odds ratio, 0.32; 95% confidence interval, 0.15-0.70). More Latinos believed that tap water would make them sick (odds ratio, 5.63; 95% confidence interval, 2.17-14.54). Approximately 40% of children who never drank tap water were not receiving fluoride supplements. Of the lowest-income families (

Assuntos
Atitude Frente a Saúde/etnologia , Proteção da Criança/etnologia , Comportamento de Ingestão de Líquido , Hispânico ou Latino/psicologia , Abastecimento de Água , Criança , Centros Comunitários de Saúde , Coleta de Dados , Filtração , Fluoretação , Fluoretos/administração & dosagem , Humanos , Saúde da População Urbana , Utah , Poluição da Água , Purificação da Água
9.
Obstet Gynecol ; 102(1): 27-30, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12850602

RESUMO

OBJECTIVE: To estimate the current prevalence of prenatal exposure to methamphetamines and other drugs of abuse among infants born in Utah and compare the results with those of a maternal substance abuse prevalence study performed in 1991 in the same geographic area. METHODS: Thirteen well baby nurseries in calendar year 2000 and six neonatal intensive care units (NICUs) in 2001-2002 collected anonymous meconium samples and associated, but nonidentifiable, demographic data on consecutively born infants. Samples were screened by enzyme immunoassay and confirmed by gas chromotography/mass spectroscopy for methamphetamines, cannabinoids, and benzoylecognine. RESULTS: Meconium samples were collected from 1202 well baby nursery infants and 317 NICU infants. There were no significant differences in the rates of positivity for methamphetamines (0.6% versus 0.4%) or marijuana (2.9% versus 1.8%) between the 1991 and 2000/2001 studies. Cocaine prevalence declined from 1.1% in 1991 to 0.3% in 2000/2001 (P =.04). The prevalence of positivity for any of these three drugs declined over the 10-year period from 4.4% to 2.4% (P =.02). The prevalence for positivity for any of these three drugs was higher in the NICUs (4.7%) than in the well baby nurseries (1.9%, P =.008). CONCLUSION: The rate of drug-positive infants declined during the decade of the 1990s in a geographic area that is experiencing a sharp rise in the use of methamphetamine among women of childbearing age. Further studies that focus on women of childbearing age who use methamphetamine may help determine factors that impact their drug use during pregnancy and after the infant is born.


Assuntos
Drogas Ilícitas/efeitos adversos , Exposição Materna/prevenção & controle , Educação de Pacientes como Assunto/organização & administração , Cuidado Pré-Natal/organização & administração , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Transtornos Relacionados ao Uso de Substâncias/prevenção & controle , Estudos de Coortes , Feminino , Humanos , Recém-Nascido , Unidades de Terapia Intensiva Neonatal , Modelos Logísticos , Mecônio/química , Análise Multivariada , Gravidez , Prevalência , Probabilidade , Medição de Risco , Detecção do Abuso de Substâncias/métodos , Utah/epidemiologia
10.
Pediatrics ; 109(6): e98, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12042592

RESUMO

A 4-year-old boy presented with fever, septic arthritis, and persistent neutropenia. Bone marrow biopsy revealed no evidence of neoplasia. Additional history disclosed that the patient had been given metamizole for pain before onset of his illness. Metamizole, a nonsteroidal antiinflammatory agent, is prohibited in the United States because of the risk of agranulocytosis but is widely used in Mexico and other countries. The increasing number of Latinos in the United States and the extensive cross-border transfer of medicines raise concerns that metamizole use and associated complications may become more frequent. After identification of the index patient, additional inquiry revealed that the patient's mother was hospitalized previously for overwhelming sepsis associated with metamizole use. These cases prompted an investigation of metamizole use in an urban pediatric clinic, which revealed that 35% of Spanish-speaking Latino families had used metamizole; 25% of these families had purchased the medication in the United States. We conclude that metamizole use is common and may be underrecognized in immigrant Latino patients. Physicians in the United States, especially those who practice primary care, hematology/oncology, and infectious diseases, must be aware of the availability and use of metamizole in specific patient populations and its potential for harmful side effects.


Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Dipirona/efeitos adversos , Emigração e Imigração/estatística & dados numéricos , Hispânico ou Latino/estatística & dados numéricos , Medicina Tradicional , Pirazolonas , Agranulocitose/induzido quimicamente , Pré-Escolar , Dipirona/uso terapêutico , Hispânico ou Latino/psicologia , Humanos , Legislação de Medicamentos/normas , Masculino , México , Neutropenia/induzido quimicamente , Dor/tratamento farmacológico , Pirazóis/efeitos adversos , Pirazóis/uso terapêutico , Sepse/induzido quimicamente , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...